Proffice and AstraZeneca plan to extend their relationship

Proffice has been appointed by AstraZeneca as its Managed Service Provider for
all staffing services for AstraZeneca's operations in Sweden. Based on this,
AstraZeneca and Proffice have agreed to enter into negotiations in order to
execute a formal agreement.
Proffice has been appointed Managed Service Provider by AstraZeneca and the
parties intend to enter into a Managed Service Provider agreement for a period
of five years with effect from spring 2013.

The partnership described above would also entail that Proffice would continue
to be one of the primary suppliers of staffing services to AstraZeneca.

AstraZeneca has also appointed Proffice to handle its holiday/intern workers in
2013, which is in addition to the appointment as Managed Service Provider, and
the parties have entered into negotiations in order to formalize such
assignment.

"We are extremely proud and pleased with the confidence AstraZeneca has shown in
us in this strategic cooperation," says Lars Kry, CEO, Proffice AB.

For further information, please contact:

Lars Kry, CEO, Proffice AB, +46 8 787 17 00, lars.kry@proffice.com.

Carina Björkefors, Head of Sales and Account Development Nordic, Proffice AB,
+46 70 833 57 07, carina.bjorkefors@proffice.com.

Proffice is one of the Nordic region's largest specialists in staffing, with
more than 10,000 employees. With commitment and by listening to what people
want, we help people and companies to find the solutions they need to develop.
The Proffice share is listed on Nasdaq OMX Stockholm, Mid Cap. www.proffice.com.

AstraZeneca is a global, innovation-driven biopharmaceutical business with a
primary focus on the discovery, development and commercialisation of
prescription medicines for gastrointestinal, cardiovascular, neuroscience,
respiratory and inflammation, oncology and infectious disease. AstraZeneca
operates in over 100 countries and its innovative medicines are used by millions
of patients worldwide. For more information please visit: www.astrazeneca.com.

Proffice Aktiebolag may be required to disclose the information provided herein
pursuant to the Securities Markets Act. The information was submitted for
publication at 08.00 a.m. CET on 21 November, 2012.